EXACT Therapeutics AS (OSL:EXTX)

EXACT Therapeutics AS Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	92	87	238	385	360	522
Market Cap Growth	-52.29%	-63.30%	-38.21%	6.94%	-31.02%	-40.97%
Enterprise Value	68	29	223	347	283	396
Last Close Price	1.46	1.38	3.76	12.00	12.00	17.40
PS Ratio	1565.50	1479.72	-	86354.11	791.98	10035.84
PB Ratio	3.01	2.84	2.06	8.54	5.53	4.93
P/TBV Ratio	3.01	2.84	2.06	8.54	5.53	4.93
EV/Sales Ratio	-	494.09	-	77902.05	621.97	7610.71
Debt / Equity Ratio	0.01	0.01	0.01	0.03	0.03	0.02
Net Debt / Equity Ratio	-0.78	-0.78	-0.86	-1.00	-1.04	-0.96
Net Debt / EBITDA Ratio	0.29	0.29	1.94	0.97	1.72	1.77
Net Debt / FCF Ratio	0.33	0.33	1.21	0.96	1.99	1.80
Asset Turnover	0.00	0.00	-	0	0.01	0
Quick Ratio	0.85	0.85	2.83	3.56	4.81	10.57
Current Ratio	1.65	1.65	3.54	3.61	4.81	10.57
Return on Equity (ROE)	-118.93%	-118.93%	-65.17%	-87.74%	-46.95%	-44.15%
Return on Assets (ROA)	-48.10%	-48.10%	-30.80%	-42.05%	-25.47%	-25.67%
Return on Capital Employed (ROCE)	-276.40%	-276.40%	-45.70%	-105.60%	-61.40%	-55.20%
Earnings Yield	-94.16%	-99.61%	-22.00%	-12.55%	-11.14%	-11.23%
FCF Yield	-78.29%	-82.83%	-34.49%	-12.31%	-9.47%	-10.87%
Buyback Yield / Dilution	-82.42%	-82.42%	-8.10%	-6.94%	-0.06%	-0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.